You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 8, 2024

CLINICAL TRIALS PROFILE FOR DARANIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for DARANIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00494507 ↗ Hyper- and Hypokalemic Periodic Paralysis Study Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 3 2007-06-01 The purpose of this study is to compare Dichlorphenamide with placebo (an inactive substance) for prevention of episodes and for improvement of strength in hyperkalemic (HYP) and hypokalemic (HOP) periodic paralysis. This study will also look at the long-term effects of Dichlorphenamide in periodic paralysis.
NCT00494507 ↗ Hyper- and Hypokalemic Periodic Paralysis Study Completed University of Rochester Phase 3 2007-06-01 The purpose of this study is to compare Dichlorphenamide with placebo (an inactive substance) for prevention of episodes and for improvement of strength in hyperkalemic (HYP) and hypokalemic (HOP) periodic paralysis. This study will also look at the long-term effects of Dichlorphenamide in periodic paralysis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for DARANIDE

Condition Name

Condition Name for DARANIDE
Intervention Trials
Hyperkalemic Periodic Paralysis 1
Hypokalemic Periodic Paralysis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for DARANIDE
Intervention Trials
Paralysis, Hyperkalemic Periodic 1
Paralysis 1
Hypokalemic Periodic Paralysis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for DARANIDE

Trials by Country

Trials by Country for DARANIDE
Location Trials
United States 8
United Kingdom 1
Italy 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for DARANIDE
Location Trials
Texas 1
Ohio 1
New York 1
Missouri 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for DARANIDE

Clinical Trial Phase

Clinical Trial Phase for DARANIDE
Clinical Trial Phase Trials
Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for DARANIDE
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DARANIDE

Sponsor Name

Sponsor Name for DARANIDE
Sponsor Trials
National Institute of Neurological Disorders and Stroke (NINDS) 1
University of Rochester 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for DARANIDE
Sponsor Trials
Other 1
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.